MTOR and cancer: Although the PI3K/mTOR inhibitors PKI-587, NVP-BEZ235, and omipalisib were demonstrated to suppress NHEJ to sensitize cancer cells to radiotherapy and/or chemotherapy [38–41], ZSTK474 did not exert the same effect.